HRTX
Heron Therapeuti
0.3582$
-6.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.0% | +49.7% | +39.3% | -1.2% | +35.1% | +39.3% | +6.1% | -4.4% | +0.3% | -14.0% | -7.1% | |
| – | +78.0% | +80.8% | +17.7% | +9.3% | +54.1% | -2.3% | -6.7% | -8.3% | -23.6% | -60.5% | -20.2% | |
| – | +58.4% | +82.3% | +17.8% | +9.5% | +54.1% | -1.0% | -5.1% | -12.3% | – | – | – | |
| – | -43.2% | +226.4% | -149.2% | – | – | -144.5% | – | – | – | -264.4% | – | |
| – | -24.5% | +188.7% | -18.6% | +259.2% | -22.0% | -4.8% | -55.6% | -39.6% | -15.3% | +10.4% | -81.4% | |
| – | +3,861.1% | – | -48.0% | -3,699.8% | -92.2% | – | -84.3% | -110.2% | – | +4.0% | -14.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +122.2% | -94.6% | +4,175.4% | +20.0% | -51.3% | -95.1% | -22.2% | – | – | – | – | |
| – | +0.0% | +0.0% | -150.0% | +0.0% | – | +0.0% | +572,834.6% | -100.0% | – | -100.0% | – | |
| – | +122.2% | -58.4% | +411.2% | +21.7% | -47.9% | -95.1% | +1,613.7% | -51.9% | -27.9% | -98.3% | +1,434.8% | |
| – | +545.6% | -2,565.7% | – | -186.0% | – | -17.0% | -143.9% | – | – | -121.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.